ENLARGED FOLLICLES IN WOMEN USING ORAL-CONTRACEPTIVES

被引:21
|
作者
BROOME, M
CLAYTON, J
FOTHERBY, K
机构
[1] ROYAL POSTGRAD MED SCH,LONDON W12 0NN,ENGLAND
[2] FAMILY PLANNING CLIN,READING RG1 5LB,BERKS,ENGLAND
[3] ROYAL BERKSHIRE HOSP,READING,BERKS,ENGLAND
关键词
ORAL CONTRACEPTIVES; PROGESTOGEN ONLY PILL; ULTRASOUND; OVARIAN CYSTS; FOLLICULAR ENLARGEMENT;
D O I
10.1016/0010-7824(95)00127-V
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Ultrasound examination of the ovaries was performed in the first and/or second half of three consecutive cycles in 3 groups of women; Group T who had been using a levonorgestrel triphasic oral contraceptive for at least 6 months, Group P who had been using a progestogen-only pill for at least 6 months, and Group C, a control group. Any follicles greater than 10 mm in diameter and any cysts were measured. Fifty-three scans were performed in Group T, 45 in Group P and 31 in Group C. Only 4 follicles were detected in 17 women in Group T compared to 10 follicles in 15 women in Group P and 7 follicles in the 10 women in Group C; all follicles were 25 mm or less in diameter except for 3 follicles in 2 women. The differences between the groups were not statistically significant. Four enlarged follicles were detected in 3 women during 53 scans in Group T, 15 in 8 women (45 scans) in Group P and only 1 in 31 scans in Group C. Based upon the proportions of scans with enlarged follicles, the difference between Groups T and P was statistically significant, indicating that the incidence of enlarged follicles was lower in women using a combined oral contraceptive than in those using a progestogen-only pill. Furthermore, the study shows that any enlarged follicles which occurred were transient.
引用
收藏
页码:13 / 16
页数:4
相关论文
共 50 条
  • [31] THE ESTROGENIC ACTIVITY OF SYNTHETIC PROGESTINS USED IN ORAL-CONTRACEPTIVES
    JORDAN, VC
    JENG, MH
    CATHERINO, WH
    PARKER, CJ
    CANCER, 1993, 71 (04) : 1501 - 1505
  • [32] PREVIOUS USE OF ORAL-CONTRACEPTIVES AND SPONTANEOUS-ABORTION
    SACKOFF, J
    KLINE, J
    SUSSER, M
    EPIDEMIOLOGY, 1994, 5 (04) : 422 - 428
  • [33] Laboratory criteria for menopause in women using oral contraceptives
    Creinin, MD
    FERTILITY AND STERILITY, 1996, 66 (01) : 101 - 104
  • [34] Assessment of DNA damage in women using oral contraceptives
    Biri, A
    Civelek, E
    Karahalil, B
    Sardas, S
    MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS, 2002, 521 (1-2) : 113 - 119
  • [35] EFFECTS OF MONOPHASIC LOW-DOSE ORAL-CONTRACEPTIVES ON FIBRIN FORMATION AND RESOLUTION IN YOUNG-WOMEN
    PETERSEN, KR
    SIDELMANN, J
    SKOUBY, SO
    JESPERSEN, J
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1993, 168 (01) : 32 - 38
  • [36] EVALUATION OF THE POSSIBLE INTERACTION OF THE ANTIFUNGAL TRIAZOLE SCH-39304 WITH ORAL-CONTRACEPTIVES IN NORMAL HEALTHY WOMEN
    LUNELL, NO
    PSCHERA, H
    ZADOR, G
    CARLSTROM, K
    GYNECOLOGIC AND OBSTETRIC INVESTIGATION, 1991, 32 (02) : 91 - 97
  • [37] ASSESSING THE RISK OF OVULATION IN INTERACTION STUDIES OF DRUGS AND ORAL-CONTRACEPTIVES
    DELAREY, N
    SCHALL, R
    LUUS, HG
    MEYER, BH
    MULLER, FO
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 1993, 31 (09) : 435 - 439
  • [38] INFLUENCE OF ORAL-CONTRACEPTIVES ON COAGULATION TESTS IN NATIVE BLOOD AND PLASMA
    KUNZ, F
    PECHLANER, C
    TABARELLI, M
    SOLDER, E
    ZWIERZINA, WD
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1990, 163 (01) : 417 - 420
  • [39] Oral contraceptives in adolescent women
    Bitzer, Johannes
    BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM, 2013, 27 (01) : 77 - 89
  • [40] ORAL-CONTRACEPTIVES, INSULIN RESISTANCE AND ISCHEMIC VASCULAR-DISEASE
    ESCHWEGE, E
    FONTBONNE, A
    SIMON, D
    THIBULT, N
    BALKAU, B
    SAINTPAUL, M
    GARNIER, P
    SENAN, C
    PAPOZ, L
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 1990, 31 (03) : 263 - 269